Letter: telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis

被引：16
|
作者：
Wiegand, J. [1 ]
Maasoumy, B. [2 ]
Buggisch, P. [3 ]
Buslau, A. [4 ]
Schiefke, I. [5 ]
Berg, T. [1 ]
Wedemeyer, H.
Sarrazin, C. [4 ]
Hinrichsen, H. [6 ]
机构：
[1] Univ Klinikum Leipzig, Klin Gastroenterol & Rheumatol, Leipzig, Germany
[2] Hannover Med Sch, Abt Gastroenterol Hepatol & Endokrinol, D-30623 Hannover, Germany
[3] Inst Interdisziplinare Med Hamburg, Hamburg, Germany
[4] Univ Frankfurt Klinikum, Med Klin 1, Frankfurt, Germany
[5] Krankenhaus St Georg Leipzig, Klin Gastroenterol & Hepatol, Leipzig, Germany
[6] Gastroenterol Hepatol Zentrum Kiel, Kiel, Germany
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 11期
关键词：
BUDD-CHIARI-SYNDROME; MANAGEMENT; TIPS;
D O I：
10.1111/apt.12748
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1342 / 1344
页数：3
相关论文
共 50 条
  • [31] Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
    Camma, Calogero
    Petta, Salvatore
    Enea, Marco
    Bruno, Raffaele
    Bronte, Fabrizio
    Capursi, Vincenza
    Cicchetti, Americo
    Colombo, Giorgio L.
    Di Marco, Vito
    Gasbarrini, Antonio
    Craxi, Antonio
    HEPATOLOGY, 2012, 56 (03) : 850 - 860
  • [32] Telaprevir and Boceprevir in African Americans with Genotype 1 Chronic Hepatitis C: Implications for Patients and Providers
    Burton, Mary Jane
    Passarella, Michael J.
    McGuire, Brendan M.
    SOUTHERN MEDICAL JOURNAL, 2012, 105 (08) : 431 - 436
  • [33] Curing a mixed genotype, 1b and 4, of hepatitis C after triple therapy based in telaprevir
    Perez Parente, Diego
    Suarez Ordonez, Sandra
    Suarez Santamaria, Marta
    Morano Amado, Luis E.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (04) : 251 - 251
  • [34] Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients
    Burney, Tabinda
    Dusheiko, Geoffrey
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (02) : 151 - 160
  • [35] The safety and tolerability of telaprevir and boceprevir based triple therapy for hepatitis C genotype 1 in an Irish patient cohort
    El-Sherif, O.
    Quinn, C.
    Hynes, B.
    McGrath, M.
    Irish, H.
    McKiernan, S.
    Norris, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S54 - S55
  • [36] Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis
    Plana, Lydia
    Peno, Laura
    Jose Urquijo, Juan
    Diago, Moises
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (05): : 356 - 358
  • [37] The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1
    Oze, T.
    Hiramatsu, N.
    Yakushijin, T.
    Yamada, R.
    Harada, N.
    Morishita, N.
    Oshita, M.
    Mita, E.
    Ito, T.
    Inui, Y.
    Inada, M.
    Tamura, S.
    Yoshihara, H.
    Imai, Y.
    Kato, M.
    Miyagi, T.
    Yoshida, Y.
    Tatsumi, T.
    Kasahara, A.
    Hayashi, N.
    Takehara, T.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (03) : 254 - 262
  • [38] Work productivity among treatment-naive patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment
    Aggarwal, J.
    Vera-Llonch, M.
    Donepudi, M.
    Suthoff, E.
    Younossi, Z.
    Goss, T. F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (01) : 8 - 17
  • [39] THE COST-EFFECTIVENESS OF TELAPREVIR TRIPLE THERAPY IN TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS IN TURKEY
    Ozdemir, O.
    VALUE IN HEALTH, 2014, 17 (07) : A670 - A670
  • [40] Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients
    Aksoz, S.
    Kaya, S.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 88 - 89
12345